US Edition
FDA Approves Merck Animal Health MOMETAMAX SINGLE to Treat Otitis Externa in Dogs
Summary by petage.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
FDA Approves Merck Animal Health MOMETAMAX SINGLE to Treat Otitis Externa in Dogs
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, New Jersey, recently announced the U.S. Food and Drug Administration (FDA) approval of MOMETAMAX SINGLE (gentamicin, posaconazole and mometasone furoate otic suspension) for dogs to treat otitis externa. The product is expected to be available at veterinary clinics nationwide in summer 2025. Canine otitis externa – in…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
